Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Coffee & heart rhythm issues | FDA grants breakthrough device designation to AAA sealing system | Wall Street stumbles

News You Need to Know Today
Coffee & heart rhythm issues | FDA grants breakthrough device designation to AAA sealing system | Wall Street stumbles
Tuesday, July 20, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Coffee consumption linked with lower risk of arrhythmia

Chronic coffee drinking is not associated with an increased risk of cardiac arrhythmias, according to new findings published in JAMA Internal Medicine.

READ MORE >
coffee
Share on Twitter Share on Facebook Share on Linkedin

Coffee consumption linked with lower risk of arrhythmia

Share on Twitter Share on Facebook Share on Linkedin
coffee
Chronic coffee drinking is not associated with an increased risk of cardiac arrhythmias, according to new findings published in JAMA Internal Medicine.
READ MORE >

FDA grants breakthrough device designation to new AAA sealing system

The new system was designed to treat juxtarenal, pararenal and suprarenal AAA.

READ MORE >
Abdominal aortic aneurysm
Share on Twitter Share on Facebook Share on Linkedin

FDA grants breakthrough device designation to new AAA sealing system

Share on Twitter Share on Facebook Share on Linkedin
Abdominal aortic aneurysm
The new system was designed to treat juxtarenal, pararenal and suprarenal AAA.
READ MORE >

Wall Street's bad day tied to Delta variant concerns

Wall Street stumbled Monday, July 19, and experts are blaming the COVID-19 Delta variant.

READ MORE >
Wall Street
Share on Twitter Share on Facebook Share on Linkedin

Wall Street's bad day tied to Delta variant concerns

Share on Twitter Share on Facebook Share on Linkedin
Wall Street
Wall Street stumbled Monday, July 19, and experts are blaming the COVID-19 Delta variant.
READ MORE >

Featured Articles

Biden administration invests $103M in reducing burnout among cardiologists, other healthcare workers

The money is part of the American Rescue Plan, the $1.9 trillion COVID-19 relief bill President Joe Biden signed into law in March.

READ MORE >
covid-money
Share on Twitter Share on Facebook Share on Linkedin

Biden administration invests $103M in reducing burnout among cardiologists, other healthcare workers

Share on Twitter Share on Facebook Share on Linkedin
covid-money
The money is part of the American Rescue Plan, the $1.9 trillion COVID-19 relief bill President Joe Biden signed into law in March.
READ MORE >

HeartFlow announces plans to merge, go public in deal worth $2.4B

Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”

READ MORE >
private equity corporatization business consolidation
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow announces plans to merge, go public in deal worth $2.4B

Share on Twitter Share on Facebook Share on Linkedin
private equity corporatization business consolidation
Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”
READ MORE >

DOACs outperform VKAs when TAVR patients require oral anticoagulation

Hoping to shed new light on the debate between DOACs and VKAs, researchers in France examined data from more than 24,000 TAVR patients.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

DOACs outperform VKAs when TAVR patients require oral anticoagulation

Share on Twitter Share on Facebook Share on Linkedin
Hoping to shed new light on the debate between DOACs and VKAs, researchers in France examined data from more than 24,000 TAVR patients.
READ MORE >

In Other News

New CT patterns provide ‘encouraging view’ of traumatic brain injury outcomes

The findings are part of the NIH-funded Transforming Research and Clinical Knowledge in Traumatic Brain Injury study, designed to understand the impact of head injuries and potential treatments.

READ MORE >
nih-brain_copy.jpg
Share on Twitter Share on Facebook Share on Linkedin

New CT patterns provide ‘encouraging view’ of traumatic brain injury outcomes

Share on Twitter Share on Facebook Share on Linkedin
nih-brain_copy.jpg
The findings are part of the NIH-funded Transforming Research and Clinical Knowledge in Traumatic Brain Injury study, designed to understand the impact of head injuries and potential treatments.
READ MORE >

High-profile $100M mammography trial gains steam, hitting 50,000-participant mark

The National Cancer Institute at one point had considered quashing the Tomosynthesis Mammography Imaging Screening Trial, but organizers are optimistic after recent upticks. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

High-profile $100M mammography trial gains steam, hitting 50,000-participant mark

Share on Twitter Share on Facebook Share on Linkedin
The National Cancer Institute at one point had considered quashing the Tomosynthesis Mammography Imaging Screening Trial, but organizers are optimistic after recent upticks. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The Best of the Month: Infective endocarditis after TAVR | CAC scanning | COVID-19 | Revenue down 73%
Looming physician shortage will affect cardiology | Updates on MIPS participation | Statin use & COVID-19 patients
Electrophysiology & Arrhythmia | June 2020
Week in Review: Infective endocarditis after TAVR | Protein boosts MI recovery | Sapien 3 TAVR outcomes | TEE injuries
Injuries & TEE-guided structural heart interventions | USPSTF on hypertension | Telemedicine for stroke survivors
Acute Coronary Syndrome | June 2020
Sapien 3 TAVR outcomes after 5 years | A fresh look at what does and does not predict death from COVID-19

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …336
    • Page 337
    • Page 338
    • Page 339
    • Current page 340
    • Page 341
    • Page 342
    • Page 343
    • Page 344 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme